Home
Site Map
Search:
About Us
Overview
Management Team
Collaborations & Contractors
Business Strategy
Investors
Products & Technology
Product Pipeline
Scientific Rationale
Clinical Development Programs
Intellectual property
Markets
Obesity
Antipsychotic drug induced weight gain
Newsroom
Press Releases
Media Coverage
Contact Us
About Us
Products & Technology
Markets
Newsroom
Contact Us
Development Updates
News
04.05.2008
Obecure Signs Strategic Agreement with Farmaceutici-Formenti of the Grunenthal Group for Manufacturing and Supply of Betahistine in Europe
02.09.2007
Obecure Phase II Trial Shows Positive Results For Histalean™ In Obese Women Under 50
©2007 All Rights Reserved to Obecure Ltd.
Disclaimer
Created by
Virtual Point Ltd.
